Elanco Animal Health Incorporated (ELAN)
| Market Cap | 7.45B |
| Revenue (ttm) | 4.49B |
| Net Income (ttm) | -1.26B |
| Shares Out | 494.33M |
| EPS (ttm) | -2.55 |
| PE Ratio | n/a |
| Forward PE | 17.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,300,075 |
| Open | 14.34 |
| Previous Close | 14.65 |
| Day's Range | 13.76 - 15.75 |
| 52-Week Range | 8.52 - 18.80 |
| Beta | 1.41 |
| Analysts | Buy |
| Price Target | 17.17 (+13.94%) |
| Earnings Date | Nov 5, 2024 |
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticid... [Read more]
Financial Performance
In 2023, Elanco Animal Health's revenue was $4.42 billion, an increase of 0.14% compared to the previous year's $4.41 billion. Losses were -$1.23 billion, 1478.2% more than in 2022.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for ELAN stock is "Buy." The 12-month stock price forecast is $17.17, which is an increase of 13.94% from the latest price.
News
Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
U.S. Food and Drug Administration approves Zenrelia, a once-daily oral JAK inhibitor for dogs with allergic and atopic dermatitis Elanco enters the estimated $1.7 billion global canine dermatology mar...
Calls of the Day: Elanco Animal Health CEO, Casey's General Store, GE Vernova, Spotify
The Investment Committee discuss the latest Calls of the Day.
FDA approves Elanco's dermatitis treatment for dogs
The U.S. Food and Drug Administration has approved Elanco Animal Health's dermatitis treatment for dogs, the health regulator's website showed on Thursday.
Elanco Animal Health Incorporated May Have Defrauded The Public And The Schall Law Firm Seeks Investor Participation In An Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Possible Securities Law Violations And Shareholders With Losses Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
Investors In Elanco Animal Health Incorporated Are Urged To Join The Schall Law Firm In A Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Possible Securities Related Infractions And Affected Shareholders Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
Investors With Losses In Elanco Animal Health Incorporated Are Invited By The Schall Law Firm To Participate In A Securities Fraud Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
Elanco Animal Health Incorporated Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Stockholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
An Inquiry Has Been Launched By The Schall Law Firm Into Whether Elanco Animal Health Incorporated Committed Securities Fraud And Investors Can Join
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
Elanco Provides Update on Contract Manufacturing Partner
GREENFIELD, Ind. , Sept. 13, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today provided an update on its relationship with contract manufacturing supplier, TriRx Speke Ltd (Tri...
Elanco Animal Health Incorporated Is Being Looked Into For Securities Law Infractions And The Schall Law Firm Wants Impacted Shareholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
The Schall Law Firm Has Launched An Inquiry Into Whether Elanco Animal Health Incorporated Committed Securities Fraud And Investors Are Urged To Join
LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
Elanco Animal Health Incorporated Is Being Looked Into For Securities Law Violations And Impacted Shareholders Can Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Anima...
Investors With Losses In Elanco Animal Health Incorporated Are Encouraged To Join The Schall Law Firm In An Investigation Into The Company's Possible Fraud
LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
Elanco Animal Health Incorporated May Have Committed Securities Fraud And The Schall Law Firm Wants Shareholders To Join An Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
The Schall Law Firm Is Looking Into Whether Elanco Animal Health Incorporated Violated Securities Regulations And Investors Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
Elanco Animal Health Incorporated May Have Engaged In Fraudulent Activities And The Schall Law Firm Seeks Shareholder Participation In An Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Inquiry Into Elanco Animal Health Incorporated
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
The Schall Law Firm Is Looking Into Whether Elanco Animal Health Incorporated Defrauded Shareholders And The Public Is Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
Investors In Elanco Animal Health Incorporated Are Invited By The Schall Law Firm To Help With An Investigation Into Securities Law Infractions
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
The Schall Law Firm Is Opening An Inquiry Into Whether Elanco Animal Health Incorporated Committed Securities Fraud And Stockholders Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal...
Elanco Animal Health Incorporated Is Being Looked Into For Possibly Violating Securities Laws And The Schall Law Firm Is Inviting Investors To Play A Part
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal H...
The Schall Law Firm Seeks The Public's Assistance In A Securities Fraud Investigation Into Elanco Animal Health Incorporated
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal H...
Shareholders In Elanco Animal Health Incorporated Are Encouraged To Help The Schall Law Firm With An Inquiry Into Whether Securities Laws Were Violated
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal H...